Crossmark

Can combination therapy with insulin and metformin improve metabolic function of the liver, in type I diabetic patients? An animal model study on CYP2D1 activity

Crossref DOI link: https://doi.org/10.1007/s40200-020-00678-y

Published Online: 2020-11-03

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rezai, Sara

Neyshaburinezhad, Navid

Rouini, Mohammadreza

Lavasani, Hoda

H. Ardakani, Yalda https://orcid.org/0000-0003-3719-6732
Funding

Funding for this research was provided by:

National Institute for Medical Research Development (grant no. 957596)
License Information

Text and Data Mining valid from 2020-11-03

Version of Record valid from 2020-11-03
More Information

Article History

Received: 7 June 2020

Revised: 8 October 2020

Accepted: 28 October 2020

First Online: 3 November 2020

Compliance with ethical standards

:

: The authors report no conflicts of interest.

Document is current

Any future updates will be listed below